Skip to main content

Anti-Human IFN-Alpha, Rabbit Serum (PAb)

Hero Region

Anti-Human IFN-Alpha, Rabbit Serum (PAb)

Catalog Number: 31101

Unconjugted Rabbit polyclonal antibody against Human IFN-Alpha suitable for use in neutralization, ELISA, Western Blot, immunoprecipitation and immunohistochemistry


Pack Size
Product Info

Specificity Binds well to human IFN-Alpha A (2a), A/D and K (6)
Tested Application
  • Neutralization
Suggested Applications*
  • Western Blot
  • Immunoprecipitation
  • Immunohistochemistry


*Please note that these applications are presented for suggested use only and have not been fully evaluated by PBL


This antibody is Immunized by recombinant human IFN-Alpha 2 (alpha 2b).


Formulation Supplied frozen as neat serum
Antigen Recombinant human interferon alpha 2 (alpha2b), expressed in E.coli
Host Species Rabbit
Bioactivity Measured by neutralization of interferon in cytopathic effect inhibition assay using A549 cells challenged with EMCV.
Storage For retention of full activity store at -70oC or below and avoid repeated freeze/thaw cycles.
Antigen Synonyms Interferon alpha, IFN alpha rabbit polyclonal, IFN-a, interferon alpha rabbit polyclonal, Leukocyte interferon, Leukocyte IFN, alpha interferon, interferon alfa, IFN alfa, interferon a, Type I interferon alpha, Type I IFN alpha

Tech Info & Data



3 Citations


  1. Kuri, et al. (2013). Influenza A Virus-Mediated Priming Enhances Cytokine Secretion by Human Dendritic Cells Infected with Streptococcus pneumoniae. Cellular Microbiology, 16 pgs. PMID: 23421931. (link)

  2. Valente, Robert, et al. (2012). Toll-Like Receptor 7 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1. PLOS One, 10 pgs. PMID: 22952664. (link)

  3. Richez, Christophe, et al. (2009). Toll-like Receptor 4 Ligands Induce IFN-α Production By Mouse Conventional Dendritic Cells and Human Monocytes After IFN-β Priming1. Journal of Immunology. PMID: 19124725. (link)




    1. Rubinstein, S., Familletti, P.C., and Pestka, S. (1981) J. Virol. 37, 755-758

    2. Budd et al. (1985) Canc. Chem. Pharm. 12:39

    3. Krug et al. Eur. J. Immunol. (2001) 31:2154

    4. Lande et al. J. Immunol. (2003) 170:1174

    5. Jego et al. Immunity (2003) 19:225

    6. Ku et al. J. Exp. Med. (2004) 200:917


    Certificate of Analysis (CoA) and Safety Data Sheet (SDS)
    31101-1 CoA

    31101-1 Certificate of Analysis

    31101-1 SDS

    31101-1 Safety Data Sheet